The medical name of Schwerta is levamlodipine benzenesulfonate, and its antihypertensive effect is not good can increase the dose, if necessary, add valsartan, metoprolol and other drugs. During the course of taking levamlodipine benzenesulfonate, attention should be paid to strengthening the monitoring of blood pressure, for patients with unsatisfactory blood pressure control, the dose of levamlodipine benzenesulfonate can be increased, in an attempt to achieve the optimal dose specified in the drug specification. Oral levamlodipine benzenesulfonate to reach the maximum dose if the blood pressure level is still high, considering that the effect of single-drug treatment is relatively poor, you can consider a combination of drugs, can be combined with valsartan at the same time in order to increase the effect of blood pressure, if accompanied by accelerated heart rate, can be added to the treatment of blood pressure reduction with metoprolol. Clinically, for patients who have reached grade 2 hypertension or above, it is often necessary to carry out a combination of applications, in order to achieve the blood pressure standard, the specific treatment program should follow the doctor’s instructions.